Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model

Stem Cells and Development

Volumn 21, Issue 17, 2012, Pages 3125-3135

  Franquesa, Marcella ^a   Herrero, Esther ^a   Torras, Joan ^a   Ripoll, Elia ^a   Flaquer, Maria ^a   Gomà, Montse ^b   Lloberas, Nuria ^a   Anegon, Ignacio ^c   Cruzado, Josep M ^a   Grinyó, Josep M ^a   Herrero Fresneda, Immaculada ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; CYTOKINE; KI 67 ANTIGEN; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SCATTER FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATROPHY; BONE MARROW TRANSPLANTATION; CHRONIC ALLOGRAFT NEPHROPATHY; COLD ISCHEMIA; CONTROLLED STUDY; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY PARENCHYMA; KIDNEY TRANSPLANTATION; LONG TERM CARE; MACROPHAGE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; SINGLE DRUG DOSE; T LYMPHOCYTE; TISSUE INJURY; TISSUE REGENERATION; TREATMENT DURATION; UPREGULATION;

ANIMALS; ATROPHY; FIBROSIS; GENES, MHC CLASS I; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKINS; KIDNEY; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PROTEINURIA; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; REGENERATION; RENAL INSUFFICIENCY; TRANSPLANTATION, HOMOLOGOUS;

ANIMALIA; RATTUS;

EID: 84869020769     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0096     Document Type: Article

References (40)

1. Herrero-Fresneda I, J Torras, M Franquesa, A Vidal, JM Cruzado, N Lloberas, C Fillat and JM Grinyo. (2006). HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms. Kidney Int 70:265-274. (Pubitemid 44086576)
2. Ge W, J Jiang, J Arp, W Liu, B Garcia and H Wang. (2010). Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression. Transplantation 90:1312-1320.
3. Zonta S, M De Martino, G Bedino, G Piotti, T Rampino, M Gregorini, F Frassoni, A Dal Canton, P Dionigi and M Alessiani. (2010). Which is the most suitable and effective route of administration for mesenchymal stem cell-based immunomodulation therapy in experimental kidney transplantation: endovenous or arterial? Transplant Proc 42: 1336-1340.
4. De Martino M, S Zonta, T Rampino, M Gregorini, F Frassoni, G Piotti, G Bedino, L Cobianchi, A Dal Canton, P Dionigi and M Alessiani. (2010). Mesenchymal stem cells infusion prevents acute cellular rejection in rat kidney transplantation. Transplant Proc 42:1331-1335.
5. Zhang W, C Qin and ZM Zhou. (2007). Mesenchymal stem cells modulate immune responses combined with cyclosporine in a rat renal transplantation model. Transplant Proc 39:3404-3408. (Pubitemid 350251482)
6. Cavaglieri RC, D Martini, MC Sogayar and IL Noronha. (2009). Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model. Transplant Proc 41:947-951.
7. Choi S, M Park, J Kim, S Hwang, S Park and Y Lee. (2009). The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev 18: 521-529.
8. Semedo P, M Correa-Costa, M Antonio Cenedeze, D Maria Avancini Costa Malheiros, M Antonia dos Reis, MH Shimizu, AC Seguro, A Pacheco-Silva and NO Saraiva Camara. (2009). Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Stem Cells 27:3063-3073.
9. Caldas HC, IM Fernandes, F Gerbi, AC Souza, MA Baptista, HJ Ramalho, RS Kawasaki-Oyama, EM Goloni-Bertollo, EC Pavarino-Bertelli, DM Braile and M Abbud-Filho. (2008). Effect of whole bone marrow cell infusion in the progression of experimental chronic renal failure. Transplant Proc 40: 853-855. (Pubitemid 351608679)
10. Ninichuk V, O Gross, S Segerer, R Hoffmann, E Radomska, A Buchstaller, R Huss, N Akis, D Schlondorff and HJ Anders. (2006). Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int 70:121-129. (Pubitemid 44000128)
11. Prodromidi EI, R Poulsom, R Jeffery, CA Roufosse, PJ Pollard, CD Pusey and HT Cook. (2006). Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells 24:2448-2455. (Pubitemid 44674305)
12. Herrero-Fresneda I, J Torras, JM Cruzado, E Condom, A Vidal, M Riera, N Lloberas, J Alsina and JM Grinyo. (2003). Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy? Am J Pathol 162:127-137. (Pubitemid 36041995)
13. Herrero-Fresneda I, J Torras, A Vidal, N Lloberas, JM Cruzado and JM Grinyo. (2005). Reduction of postischemic immune inflammatory response: an effective strategy for attenuating chronic allograft nephropathy. Transplantation 79:165-173.
14. Herrero-Fresheda Z. Experimental kidney trasplant. www.renal. transplantation.com.
15. Remy S, L Tesson, C Usal, S Menoret, V Bonnamain, V Nerriere-Daguin, J Rossignol, C Boyer, TH Nguyen, et al. (2010). New lines of GFP transgenic rats relevant for regenerative medicine and gene therapy. Transgenic Res 19:745-763.
16. Sis B, M Mengel, M Haas, RB Colvin, PF Halloran, LC Racusen, K Solez, WM Baldwin, 3rd, ER Bracamonte, et al. (2010). Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 10:464-471.
17. Hill M, V Pereira, C Chauveau, R Zagani, S Remy, L Tesson, D Mazal, L Ubillos, R Brion, et al. (2005). Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase. FASEB J 19:1957-1968. (Pubitemid 41759741)
18. Casiraghi F, M Noris and G Remuzzi. (2010). Immunomodulatory effects of mesenchymal stromal cells in solid organ transplantation. Curr Opin Organ Transplant 15:731-737.
19. Perico N, F Casiraghi, M Introna, E Gotti, M Todeschini, RA Cavinato, C Capelli, A Rambaldi, P Cassis, et al. (2011). Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. Clin J Am Soc Nephrol 6:412-422.
20. Diamond JR, NL Tilney, J Frye, G Ding, J McElroy, I Pesek-Diamond and H Yang. (1992). Progressive albuminuria and glomerulosclerosis in a rat model of chronic renal allograft rejection. Transplantation 54:710-716.
21. Yang X, I Balakrishnan, B Torok-Storb and MM Pillai. (2012). Marrow Stromal Cell Infusion Rescues Hematopoiesis in Lethally Irradiated Mice despite Rapid Clearance after Infusion. Adv Hematol 2012:142530.
22. Crop MJ, CC Baan, SS Korevaar, JN Ijzermans,MPescatori, AP Stubbs, WF van Ijcken, MH Dahlke, E Eggenhofer, W Weimar and MJ Hoogduijn. (2010). Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells. Clin Exp Immunol 162:474-486.
23. Crop MJ, SS Korevaar, R de Kuiper, JN Ijzermans, NM van Besouw, CC Baan, W Weimar and MJ Hoogduijn. (2011). Human mesenchymal stem cells are susceptible to lysis by CD8+ T-cells and NK cells. Cell Transplant [Epub ahead of print]; Doi: 10.727/096368910X564076
24. Mathew JM, RO Garcia-Morales, M Carreno, Y Jin, L Fuller, B Blomberg, R Cirocco, GW Burke, G Ciancio, et al. (2003). Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation. Transpl Immunol 11:307-321. (Pubitemid 37120550)
25. Mazo M, JJ Gavira, G Abizanda, C Moreno, M Ecay, M Soriano, P Aranda, M Collantes, E Alegria, et al. (2010). Transplantation of mesenchymal stem cells exerts a greater longterm effect than bone marrow mononuclear cells in a chronic myocardial infarction model in rat. Cell Transplant 19:313-328.
26. Ghanem A, A Ziomka, B Krausgrill, K Schenk, C Troatz, T Miszalski-Jamka, G Nickenig, K Tiemann and J Muller-Ehmsen. (2009). Functional impact of targeted closed-chest transplantation of bone marrow cells in rats with acute myocardial ischemia/reperfusion injury. Cell Transplant 18:1289-1297.
27. Muller AJ, JB DuHadaway, PS Donover, E Sutanto-Ward and GC Prendergast. (2005). Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat Med 11:312-319. (Pubitemid 40460560)
28. DelaRosa O, E Lombardo, A Beraza, P Mancheno-Corvo, C Ramirez, R Menta, L Rico, E Camarillo, L Garcia, et al. (2009). Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells. Tissue Eng Part A 15:2795-2806.
29. English K, FP Barry, CP Field-Corbett and BP Mahon. (2007). IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells. Immunol Lett 110:91-100. (Pubitemid 46830943)
30. Popp FC, E Eggenhofer, P Renner, P Slowik, SA Lang, H Kaspar, EK Geissler, P Piso, HJ Schlitt and MH Dahlke. (2008). Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate. Transpl Immunol 20:55-60.
31. Comoli P, F Ginevri, R Maccario, MA Avanzini, M Marconi, A Groff, A Cometa, M Cioni, L Porretti, et al. (2008). Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation. Nephrol Dial Transplant 23:1196-1202. (Pubitemid 351767482)
32. Vieira JM, Jr., E Mantovani, LT Rodrigues, H Delle, IL Noronha, CK Fujihara and R Zatz. (2005). Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. Nephrol Dial Transplant 20:1582-1591. (Pubitemid 41418580)
33. Liu N, E Tolbert, M Pang, M Ponnusamy, H Yan and S Zhuang. (2011). Suramin inhibits renal fibrosis in chronic kidney disease. J Am Soc Nephrol 22:1064-1075.
34. Togel F, J Isaac, Z Hu, K Weiss and C Westenfelder. (2005). Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 67:1772-1784. (Pubitemid 40577712)
35. Ponomaryov T, A Peled, I Petit, RS Taichman, L Habler, J Sandbank, F Arenzana-Seisdedos, A Magerus, A Caruz, et al. (2000). Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 106:1331-1339.
36. Mishra J, Q Ma, A Prada, M Mitsnefes, K Zahedi, J Yang, J Barasch and P Devarajan. (2003). Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14:2534-2543. (Pubitemid 37169339)
37. Gobe GC, R Buttyan, KR Wyburn, MR Etheridge and PJ Smith. (1995). Clusterin expression and apoptosis in tissue remodeling associated with renal regeneration. Kidney Int 47:411-420.
38. Vinuesa E, A Sola, M Jung, V Alfaro and G Hotter. (2008). Lipocalin-2-induced renal regeneration depends on cytokines. Am J Physiol Renal Physiol 295:F1554-F1562.
39. Homsi E, P Janino, SK Biswas, S Mizuno, T Nakamura and JB Lopes de Faria. (2007). Attenuation of glycerol-induced acute kidney injury by previous partial hepatectomy: role of hepatocyte growth factor/c-met axis in tubular protection. Nephron Exp Nephrol 107:e95-e106. (Pubitemid 350073619)
40. Bailly V, Z Zhang, W Meier, R Cate, M Sanicola and JV Bonventre. (2002). Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J Biol Chem 277:39739-39748. (Pubitemid 35190957)